Health and Economic Benefits of Compulsory RegularVaccination in the Slovak Republic. II. Poliomyelitis

Czech version

Authors: H. Hudečková ¹; Š. Straka ²
Authors‘ workplace: Odbor epidemiológie, Štátny zdravotný ústav, Martin 2 Ústav epidemiológie, Jesseniova lekárska fakulta Univerzity Komenského, Martin ¹
Published in: Epidemiol. Mikrobiol. Imunol. , 2000, č. 2, s. 59-63
Category:

Overview

The authors compared intervention strategy (vaccination) and non-intervention strategy (no vac-cination). For the evaluation of health and financial effectiveness of regular polio vaccination theauthors used the modelling of treatment of polio cases in 1957, and vaccination costs in 1996 – themost recent year with available statistical data from the Slovak Republic. From these model yearsthey calculated: the cost saving (11 919 106 Sk), cost-effectiveness ratio (79 944 Sk) and the net costof vaccination (3 047 786 Sk). Simultaneously, they present a breakdown of cost-benefit analysis.

Key words:
polio vaccination – cost saving – cost-effectiveness – cost-benefit.

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Hygiene and epidemiology Medical virology Clinical microbiology

Characteristics of Coagulase-negative Staphylococci Isola-ted from Haemocultures

Filamentous Fungi Infecting Man. Alphabe-tical Survey of Mycotic Agents with Data on their Systematic Classification and onthe Localization of Individual Diseases

Experimental Infection with Trichophyton rubrum in Animals

Application of Results of Monitoring in the Practice of District Hy-gienists

History of the Czech J. E. Purkyně Medical Association

Article was published in

Epidemiology, Microbiology, Immunology

2000 Issue 2